Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?

Clin Infect Dis. 2011 Jan 1;52(1):89-93. doi: 10.1093/cid/ciq016.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antitubercular Agents / pharmacology
  • Biological Therapy / adverse effects*
  • Biological Therapy / methods
  • Drug Resistance, Bacterial*
  • Humans
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Isoniazid / pharmacology*
  • Microbial Sensitivity Tests
  • Mycobacterium bovis / drug effects*
  • Mycobacterium bovis / immunology
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antitubercular Agents
  • Isoniazid